276 results about "Kidney stone" patented technology

The present disclosure is directed to a medical device. Systems and methods are provided for utilizing a laser to break a kidney stones into smaller fragments and / or dust, and removing particles, stone fragments and / or stone dust from a patient. The medical device may include a tube having a distal end and a proximal end, a first lumen extending from the proximal end to the distal end of the tube and in fluid communication with the distal end and a plurality of side ports located at a distal portion of the tube, and a second lumen extending from the proximal end to the distal end of the tube.

The present invention relates to compounds which are inhibitors of sodium dependent glucose co-transporter-2 (SGLT-2). These compounds are used in the treatment of various disorders, including diabetes, impaired glucose tolerance, insulin resistance, retinopathy, nephropathy, neuropathy, cataracts, hyperglycemia, hyperinsulinemia, hyperchlolesterolemia, elevated blood level of free fatty acids or glycerol, hyperlipidemia, hypertriglyceridemia, obesity, wound healing, tissue ischemia, atherosclerosis, and hypertension. These compounds and compositions are also useful for treating and preventing kidney stones, hyperuricemia, gout, and hyponatremia. Methods of making these compounds are also described in the present invention.

The present invention relates to identifying the risk of a subject developing renal stones utilizing an assessment of PTH agonist, antagonist and / or total PTH levels, optionally together with an assessment of serum and / or urine calcium levels and / or other analytes. The present description further relates to monitoring and guiding treatment for renal stones and kits useful therefore.

The invention discloses a liftable kidney stone treatment apparatus with a support device in the technical field of medical equipment, comprising a movable plank bed, a pillow is arranged on the top of the movable plank bed, and a fixed plank bed is arranged at the right end of the movable plank bed. The movable plank bed and the fixed plank bed are connected by hinges, the top of the fixed plank bed is provided with a support device, the top of the support device is provided with a sliding support frame, the front and rear side walls of the fixed plank bed are provided with chute, the sliding support The bottom inner wall of the frame is provided with a sliding block matched with the chute. In the present invention, a movable plank bed, a limit block, a lifting screw, a rotating screw and a manual crank are arranged, and the rotating screw is driven to rotate by the manual crank, and the rotating screw and the lifting The screw is matched to make the lifting screw move up and down, and the lifting screw drives the angle adjustment of the movable plank, which is convenient for the patient to get up and down.

A method of preventing or inhibiting L-cystine crystallization using the compounds of formula I is disclosed.R1a—O-(-A-L-)m-A-O—R1b  I,wherein A, L, R1a, R1b, and m are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of conditions that are causally related to L-cystine crystallization, such as comprising (but not limited to) kidney stones.

A method of preventing or inhibiting L-cystine crystallization is disclosed, using the compounds of formula I:R1a—[O]v-(-A-L-)m-A-[O]v—R1b  I,wherein A, L, R1a, R1b, m, and v are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of conditions that are causally related to L-cystine crystallization, such as comprising (but not limited to) kidney stones.

The invention relates to a traditional Chinese medicine for treating kidney stone. The traditional Chinese medicine for treating the kidney stone consists of 15 g of climbing fern, 35 g of loosestrife, 15 g of gizzard pepsin, 15 g of talcum powder and 5 g of liquoric root, wherein the accuracy of the proportion of the medicines is + / -5 percent. A use method of the traditional Chinese medicine comprises the following steps of: mixing the medicines together; placing in a medicine pot; placing in 1,000 g of clear water to soak for 1 hour; boiling with intense fire; slowly decocting with slow fire until 400 g of water is remained; and taking after the medicine is at normal temperature, a dose each day. The traditional Chinese medicine is taken in one hour after dinner each day, seven doses are continuously taken for a period of treatment, and another seven doses are taken after three days, so that the kidney stone can be cured. According to the traditional Chinese medicine for treating the kidney stone, clinical use proves that not only the symptom of a patient can be relieved during taking after one to three periods of treatment are used, but also the kidney stone can be completely cured after the traditional Chinese medicine is taken; and the traditional Chinese medicine has a particularly obvious effect and no toxic or side effect and is low in cost.

A method for producing pear residue dietary fiber biscuits includes the specific steps that firstly, butter is softened and beaten at room temperature; secondly, flour is mixed with the mixture evenly; thirdly, dough is prepared; fourthly, the dough is fermented; fifthly, the dough is pressed by means of a mould; sixthly, baking is conducted; seventhly, cooling and packaging are carried out. The pear residue dietary fiber biscuits are beneficial to gastro-intestinal digestion, and have the advantages of regulating intestinal balance, improving intestinal flora, keeping human intestinal tract circulation smooth, clearing away toxin and relaxing the bowels, reducing diabetes, improving human immunity, reducing kidney calculi and preventing cardiovascular diseases, diabetes and hypertension. Compared with traditional biscuits, the pear residue dietary fiber biscuits have the advantages of being low in grease, sugar and calorie. The practical manufacturing method of the pear residue dietary fiber biscuits is provided for utilization of residues generated in juice production, maximum resource utilization is achieved, and the function of saving resources is achieved. The biscuits have good health-care functions, market prospects and popularization value.

Described is a kit for producing a crosslinked gel for surrounding urinary calculi and / or fragments thereof, more particularly kidney stones and / or fragments thereof, comprising a composition (A) comprising one or several cationically crosslinkable polymer(s), and a composition (B) comprising one or several crosslinking agent(s) for crosslinking the cationically crosslinkable polymer(s), wherein composition (A) and / or composition (B) additionally comprise(s) magnetizable particles or the kit additionally comprises a composition (C) that contains magnetizable particles. Upon contact of composition (A) with composition (B) in a region of the urinary tract, more particularly the kidney, that contains urinary calculi and / or fragments thereof, more particularly kidney stones and / or fragments thereof, a crosslinked gel is formed that partly or fully surrounds the urinary calculi and / or fragments thereof, more particularly kidney stones and / or fragments thereof, and that contains the magnetizable particles. The gel together with the urinary calculi and / or fragments thereof, more particularly kidney stones and / or fragments thereof, can then be removed from the body by using magnetic interactions.

The invention relates to an instant oral liquid for kidney stone, comprising the following medicine materials in portions by weight: 3-10 portions of cinnamon, 6-15 portions of white atractylodes rhizome, 6-15 portions of grifola, 6-30 portions of poria cocos, 6-15 portions of oriental waterplantain rhizome, 20-60 portions of longhairy antenoron herb, 6-15 portions of lygodium japonicum and 6-15 portions of cluster mallow fruit. The instant oral liquid for kidney stone is also characterized by comprising the following medicine materials in portions by weight: 3-30 portions of plaster stone, 6-15 portions of rhizoma anemarrhenae, 5-10 portions of fructus forsythiae, 6-12 portions of ginseng, 15-60 portions of astragalus mongholicus, 10-30 portions of cornus officinalis, 15-30 portions of rehmanniae praeparatum and 5-10 portions of radix glycyrrhizae. The dosage of herbal medicines in the formulation is increased by 1,000 times, about 800L of water is added to decoct about 160L of the liquid, and the plaster stones are ground into fine powder to evenly mix into a decocting liquid so as to package into 100ml for each bottle. The invention has the advantages that the traditional Chinese medicine for clearing heat, promoting diuresis and eliminating urolith is added on the basis of clearing fire away and tonifying yin and qi with the favorable treatment effect, 300 cases of urinarystone are clinically treated in the clinical experiment with 100 percent of the cure rate, and patients have no obvious pain in the process of urolith elimination.

The invention discloses a pharmaceutical composition for treating kidney stone. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 16-24 parts of gravel grass, 5-13 parts of lysimachia christinae hance, 5-13 parts of plantain herb, 5-13 parts of endothelium corneum gigeriae galli, 5-13 parts of dianthus superbus and 5-13 parts of pyrrosia lingua as active components. The defects of the existing drug for treating the kidney stone are overcome, and pharmaceutical composition with a good treatment effect on the kidney stone is provided.

The invention discloses a calculus enzyme which is an enzyme capable of defusing calculus. The calculus enzyme can be applied to a human body as food, beverage, health-care products, drugs or injection to prevent and defuse body stones. The calculus enzyme is convenient to use, mild in reaction, and free of toxic and side effects, and can prevent and treat renal calculus, urinary stones, gastric concretion, gall-stones and the like inside the human body. Clinical practices prove that the stones with different sizes inside the human body can be mildly defused and removed without crushing the stones. The preparation method of the calculus enzyme comprises the following steps: adopting the following raw materials in parts by weight: 20-30 parts of carbon source, 1-10 parts of nitrogen source and 40-94 parts of water, and 1-10 parts of nutritive salt and 1-5 parts of auxin serving auxiliaries; inducing microorganisms to ferment, culture, digest, separate and concentrate, so as to obtain a liquid crude product by adopting an artificial ox-gall calculi or body stones by a solid fermentation method; carrying out spray drying to obtain a solid crude product; filtering and refining the liquid crude product, so as to obtain a liquid refined product; separating, settling, centrifuging, and freeze-drying the liquid refined product, so as to obtain a lyophilized product, namely a solid refined product.

The present invention relates to compounds which are inhibitors of sodium dependent glucose co-transporter-2 (SGLT-2). These compounds are used in the treatment of various disorders, including diabetes, impaired glucose tolerance, insulin resistance, retinopathy, nephropathy, neuropathy, cataracts, hyperglycemia, hyperinsulinemia, hyperchlolesterolemia, elevated blood level of free fatty acids or glycerol, hyperlipidemia, hypertriglyceridemia, obesity, wound healing, tissue ischemia, atherosclerosis, and hypertension. These compounds and compositions are also useful for treating and preventing kidney stones, hyperuricemia, gout, and hyponatremia. Methods of making these compounds are also described in the present invention.